DK1768691T3 - Aequorinholdige præparater og fremgangsmåder til anvendelse af samme - Google Patents

Aequorinholdige præparater og fremgangsmåder til anvendelse af samme

Info

Publication number: DK1768691T3
Authority: DK; Denmark
Prior art keywords: aequorin; methods; same; containing preparations; preparations
Prior art date: 2004-06-21

Application number

DK05766584.6T

Other languages

English (en)

Inventor

Mark Y Underwood

Original Assignee

Quincy Bioscience Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-21

Filing date

2005-06-21

Publication date

2013-07-01

2005-06-21 Application filed by Quincy Bioscience Llc filed Critical Quincy Bioscience Llc

2013-07-01 Application granted granted Critical

2013-07-01 Publication of DK1768691T3 publication Critical patent/DK1768691T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Zoology (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Toxicology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)

DK05766584.6T 2004-06-21 2005-06-21 Aequorinholdige præparater og fremgangsmåder til anvendelse af samme DK1768691T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/872,795 US20060229243A1 (en)	2004-06-21	2004-06-21	Aequorin-containing compositions and methods of using same
PCT/US2005/021770 WO2006010004A2 (en)	2004-06-21	2005-06-21	Aequorin-containing compositions and methods of using same

Publications (1)

Publication Number	Publication Date
DK1768691T3 true DK1768691T3 (da)	2013-07-01

Family

ID=35785748

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05766584.6T DK1768691T3 (da)	2004-06-21	2005-06-21	Aequorinholdige præparater og fremgangsmåder til anvendelse af samme

Country Status (20)

Country	Link
US (3)	US20060229243A1 (da)
EP (2)	EP2545934B1 (da)
JP (1)	JP4971150B2 (da)
KR (1)	KR101213555B1 (da)
CN (1)	CN1997383B (da)
AU (1)	AU2005265266B2 (da)
BR (1)	BRPI0512392B1 (da)
CA (1)	CA2571542C (da)
CY (1)	CY1114307T1 (da)
DK (1)	DK1768691T3 (da)
ES (1)	ES2422173T3 (da)
IL (1)	IL180195A (da)
MX (1)	MXPA06015037A (da)
NZ (1)	NZ552274A (da)
PL (1)	PL1768691T3 (da)
PT (1)	PT1768691E (da)
SG (1)	SG153848A1 (da)
SI (1)	SI1768691T1 (da)
WO (1)	WO2006010004A2 (da)
ZA (1)	ZA200610688B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060229243A1 (en) *	2004-06-21	2006-10-12	Quincy Resource Group, Inc.	Aequorin-containing compositions and methods of using same
GB0625678D0 (en) *	2006-12-21	2007-01-31	Lux Biotechnology Ltd	Composition and method for detection of demineralisation
MX2010009753A (es) *	2008-03-11	2010-09-30	Quincy Bioscience Llc	Composiciones que contienen apoaecuorina y metodos de uso de las mismas.
JP2010143860A (ja) *	2008-12-19	2010-07-01	Chisso Corp	タンパク質の安定化剤
US20110130336A1 (en) *	2009-10-16	2011-06-02	Quincy Bioscience, Llc	Method of treating ischemic injury using apoaequorin
CN103261415B (zh) *	2010-12-24	2016-08-10	大塚制药株式会社	检测生理活性物质的生物测定法
KR102009932B1 (ko) *	2011-11-15	2019-08-12	퀸시 바이오사이언스 엘엘씨	허혈로 인한 뉴런 손상을 감소시키기 위한 아포에쿼린
GB201700317D0 (en)	2017-01-09	2017-02-22	Calcivis Ltd	Detection device
USD1042180S1 (en)	2020-05-28	2024-09-17	Calcivis Limited	Dental detection device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001240855A (ja) *	2000-03-01	2001-09-04	Masashi Sugimoto	生物発光方法及び発光物品
US6800492B2 (en) *	2000-06-01	2004-10-05	Institute Pasteur	Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level
AU2001268328A1 (en) *	2000-06-12	2001-12-24	University Of Maryland Biotechnology Institute	Method of controlling the binding of calmyrin to presenilin
US20060229243A1 (en) *	2004-06-21	2006-10-12	Quincy Resource Group, Inc.	Aequorin-containing compositions and methods of using same

2004
- 2004-06-21 US US10/872,795 patent/US20060229243A1/en not_active Abandoned
2005
- 2005-06-21 CA CA2571542A patent/CA2571542C/en not_active Expired - Lifetime
- 2005-06-21 NZ NZ552274A patent/NZ552274A/en not_active IP Right Cessation
- 2005-06-21 JP JP2007518179A patent/JP4971150B2/ja not_active Expired - Lifetime
- 2005-06-21 SI SI200531724T patent/SI1768691T1/sl unknown
- 2005-06-21 KR KR1020077001461A patent/KR101213555B1/ko not_active Expired - Lifetime
- 2005-06-21 EP EP12188025.6A patent/EP2545934B1/en not_active Expired - Lifetime
- 2005-06-21 AU AU2005265266A patent/AU2005265266B2/en not_active Expired
- 2005-06-21 MX MXPA06015037A patent/MXPA06015037A/es active IP Right Grant
- 2005-06-21 US US11/571,043 patent/US7671015B2/en not_active Expired - Lifetime
- 2005-06-21 PT PT57665846T patent/PT1768691E/pt unknown
- 2005-06-21 EP EP05766584.6A patent/EP1768691B1/en not_active Expired - Lifetime
- 2005-06-21 WO PCT/US2005/021770 patent/WO2006010004A2/en not_active Ceased
- 2005-06-21 BR BRPI0512392-5A patent/BRPI0512392B1/pt active IP Right Grant
- 2005-06-21 PL PL05766584T patent/PL1768691T3/pl unknown
- 2005-06-21 DK DK05766584.6T patent/DK1768691T3/da active
- 2005-06-21 ES ES05766584T patent/ES2422173T3/es not_active Expired - Lifetime
- 2005-06-21 SG SG200904273-0A patent/SG153848A1/en unknown
- 2005-06-21 CN CN200580024585XA patent/CN1997383B/zh not_active Expired - Lifetime
2006
- 2006-12-19 IL IL180195A patent/IL180195A/en active IP Right Grant
- 2006-12-19 ZA ZA200610688A patent/ZA200610688B/en unknown
2010
- 2010-01-27 US US12/694,427 patent/US20100152117A1/en not_active Abandoned
2013
- 2013-06-14 CY CY20131100486T patent/CY1114307T1/el unknown

Also Published As

Publication number	Publication date
CA2571542C (en)	2014-08-19
WO2006010004A2 (en)	2006-01-26
US20080287350A1 (en)	2008-11-20
CN1997383B (zh)	2011-01-05
CY1114307T1 (el)	2016-08-31
JP4971150B2 (ja)	2012-07-11
WO2006010004A3 (en)	2007-03-08
SG153848A1 (en)	2009-07-29
SI1768691T1 (sl)	2013-07-31
EP2545934B1 (en)	2014-12-10
MXPA06015037A (es)	2007-07-11
CN1997383A (zh)	2007-07-11
HK1109576A1 (en)	2008-06-13
EP1768691A4 (en)	2010-08-04
EP1768691A2 (en)	2007-04-04
US20100152117A1 (en)	2010-06-17
BRPI0512392A (pt)	2008-03-11
ES2422173T3 (es)	2013-09-09
JP2008503581A (ja)	2008-02-07
CA2571542A1 (en)	2006-01-26
PT1768691E (pt)	2013-06-20
US20060229243A1 (en)	2006-10-12
KR20070070154A (ko)	2007-07-03
EP1768691B1 (en)	2013-05-22
BRPI0512392B1 (pt)	2022-12-13
EP2545934A1 (en)	2013-01-16
PL1768691T3 (pl)	2013-09-30
AU2005265266A1 (en)	2006-01-26
NZ552274A (en)	2010-06-25
AU2005265266B2 (en)	2011-05-12
IL180195A (en)	2014-03-31
ZA200610688B (en)	2007-12-27
US7671015B2 (en)	2010-03-02
IL180195A0 (en)	2007-06-03
KR101213555B1 (ko)	2012-12-18

Publication	Publication Date	Title
DK1805312T3 (da)	2009-10-19	Fremgangsmåder og midler til fremstilling af hyaluronan
NO20032220D0 (no)	2003-05-15	Löfteverktöy II og fremgangsmåte for anvendelse av samme
DK1877090T3 (da)	2014-04-14	Trimert ox40-immunoglobulin-fusionsprotein og fremgangsmåder til anvendelse heraf
DK1948852T3 (da)	2019-01-02	Hovedelektrode og fremgangsmåde til dannelse af hovedelektroden
IS8204A (is)	2006-07-01	Tæki og aðferð til að hluta niður
DK1765327T3 (da)	2014-11-03	Forbindelser, sammensætninger og fremgangsmåder
DK1575416T3 (da)	2014-01-13	Fremgangsmåder til diagnosticering af præeklampsi
EP1784219A4 (en)	2010-02-17	STABILIZING FORMULATIONS
DK1701968T3 (da)	2015-06-22	Immunogene peptid-bærer-konjugater og fremgangsmåder til deres fremstilling
DK2929891T3 (da)	2020-05-11	Fremgangsmåde til modulering af appetitten
DK1718155T3 (da)	2011-10-03	Fremgangsmåder til anvendelse af probiotiske bifidobakterier til selskabsdyr
EP1895838A4 (en)	2013-03-06	COMPOSITIONS AND METHODS
PL2279729T3 (pl)	2017-02-28	Preparaty o kontrolowanym uwalnianiu
DK1725253T3 (da)	2014-07-07	Medikamenter og fremgangsmåder til behandling af hovedpine
DK1965763T3 (da)	2020-02-10	Stabile enzympræparater og fremgangsmåder til anvendelse heraf
IS7726A (is)	2005-03-04	Pyrazólólpyridín og aðferðir til þess að búa þau til og nota
DK1732548T4 (da)	2023-11-20	Fremgangsmåder til anvendelse af aminopyridin-depotpræparater
NO20054709D0 (no)	2005-10-13	Sammenfoyningssystem og anvendelse av dette
DE502004002225D1 (de)	2007-01-18	Selbstemulgierende Zubereitungen
DK1601744T3 (da)	2012-08-20	Forgasningsapparat og fremgangsmåde
DK1817055T3 (da)	2013-04-08	Ovr110-antistofsammensætninger og fremgangsmåder til anvendelse heraf
IS7572A (is)	2006-05-30	Aðferð og efni til lækninga
DK1743101T3 (da)	2009-09-07	Centrifugalpumpe og fremgangsm de til fremstilling af samme
NO20044012D0 (no)	2004-09-23	Fremgangsmate og et system
DK1768691T3 (da)	2013-07-01	Aequorinholdige præparater og fremgangsmåder til anvendelse af samme